Skip to Main Content

Author Details

Ashley E Ross
Northwestern University
2003
188
51
PMIDPaper TitleJournal TitlePublished Year
36418491Relationships between holmium laser enucleation of the prostate and prostate cancer.Nat Rev Urol2023
37525535Use of the Decipher genomic classifier among men with prostate cancer in the United States.JNCI Cancer Spectr2023
37750841The utility of [<sup>18</sup>F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate-Resistant Prostate Cancer Patients (nmCRPCp): diagnostic performance and impact on management.Br J Radiol2023
37619655A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy.Front Neuroendocrinol2023
35551235Real-world use of MRI for risk stratification prior to prostate biopsy.Prostate Cancer Prostatic Dis2023
37060201A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.Cancer2023
37042807Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.J Urol2023
37012549Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial.Nat Med2023
37208135Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplications.BMJ Open2023
36973367Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men.Prostate Cancer Prostatic Dis2023
37164128Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.Ann Oncol2023
36585434MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.Prostate Cancer Prostatic Dis2023
36743402Prostate Cancer Tumor Volume and Genomic Risk.Eur Urol Open Sci2023
36708787WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer.Int J Radiat Oncol Biol Phys2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35347252Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies.Prostate Cancer Prostatic Dis2022
35013522Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics.Prostate Cancer Prostatic Dis2022
35096145Concurrent placement of SpaceOAR gel and gold fiducials during HoLEP: a case report.Ther Adv Urol2022
35243391Role of Prophylactic Antibiotics in Transperineal Prostate Biopsy: A Systematic Review and Meta-analysis.Eur Urol Open Sci2022
34906585Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.Urology2022
35333400Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.Cancer2022
34196715Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.JAMA Netw Open2021
33649503Local anaesthetic techniques for performing transperineal prostate biopsy.Nat Rev Urol2021
33868943Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomy.Urol Case Rep2021
33840559Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer.Eur Urol2021
33721334Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.Cancer2021
34902034Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.JAMA Netw Open2021
34988484How to Treat Prostate Cancer With Androgen Deprivation and Minimize Cardiovascular Risk: A Therapeutic Tightrope.JACC CardioOncol2021
34762074Genetics in prostate cancer: implications for clinical practice.Curr Opin Support Palliat Care2021
34458727Perceptions of partial gland ablation for prostate cancer among men on active surveillance: A qualitative study.BMJ Surg Interv Health Technol2021
33985797Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.Eur Urol2021
34268609Timing of adjuvant chemotherapy after laparotomy for Wilms tumor and neuroblastoma.Pediatr Surg Int2021
30992160Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.Eur Urol2020
35050780Development and Validation of a Genomic Tool to Predict Seminal Vesicle Invasion in Adenocarcinoma of the Prostate.JCO Precis Oncol2020
33173205Surgical management of high-risk, localized prostate cancer.Nat Rev Urol2020
32215577Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.JAMA Oncol2020
32524295Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer.Med Oncol2020
32461072Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.Eur Urol2020
32259468Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.J Urol2020
32367635Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.BJU Int2020
31611635A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer.Prostate Cancer Prostatic Dis2020
31201249Prospective Evaluation of PSMA-Targeted <sup>18</sup>F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer.J Nucl Med2020
31115751Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.Mol Imaging Biol2020
30279579PTEN status assessment in the Johns Hopkins active surveillance cohort.Prostate Cancer Prostatic Dis2019
31839878A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host.Oncotarget2019
31766092Editorial Comment.J Urol2019
30191396Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.World J Urol2019
30077557A Clinician's Guide to Next Generation Imaging in Patients With Advanced Prostate Cancer (RADAR III).J Urol2019
31515456Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.Clin Cancer Res2019
30811282Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone.J Clin Oncol2019
  • 1 - 50 of 188

Recommended Authors

Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Career Start Year 2012
Number of shared co-authors 35
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Career Start Year 2012
Number of shared co-authors 3
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 28
Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 43
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 5
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 32
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 22
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 35
Heather H Cheng
Fred Hutchinson Cancer Center, University of Washington
Career Start Year 2002
Number of shared co-authors 58
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 37
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 15
Eleni Efstathiou
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 37
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 11
Vincent J Gnanapragasam
University of Cambridge
Career Start Year 1999
Number of shared co-authors 13
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Career Start Year 1998
Number of shared co-authors 16
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 16
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 19
Inge M van Oort
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 24
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 37
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Career Start Year 1993
Number of shared co-authors 28
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 8
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 84
Fred Saad
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 63
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 55
Mark Frydenberg
Monash University
Career Start Year 1988
Number of shared co-authors 37
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 30
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 17
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 55
Dominique Trudel
Institut du cancer de Montreal
Career Start Year 1985
Number of shared co-authors 20
Oliver Sartor
Tulane University School of Medicine
Career Start Year 1983
Number of shared co-authors 76

Collaborators

Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 90
Elai Davicioni
Veracyte Inc.
Co-authored papers 50
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 49
Eric A Klein
Cleveland Clinic
Co-authored papers 38
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 34
Robert B Den
Thomas Jefferson University Hospital
Co-authored papers 31
Nicholas Erho
GenomeDx Biosciences Inc.
Co-authored papers 27
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 26
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 26
Phuoc T Tran
University of Maryland School of Medicine
Co-authored papers 26
Bruce J Trock
Johns Hopkins University School of Medicine
Co-authored papers 25
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 24
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 23
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 22
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Co-authored papers 19
Stephen J Freedland
Cedars-Sinai Medical Center
Co-authored papers 19
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Co-authored papers 17
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 14
Theodore L DeWeese
Johns Hopkins University School of Medicine
Co-authored papers 14
Danny Y Song
Johns Hopkins University School of Medicine
Co-authored papers 14
Ridwan Alam
Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 13
Curtiland Deville
Johns Hopkins University
Co-authored papers 13
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 12
Amar U Kishan
University of California los angeles
Co-authored papers 11
Christian P Pavlovich
Co-authored papers 11
Phillip M Pierorazio
Co-authored papers 11
Mandeep Takhar
GenomeDx Biosciences Inc.
Co-authored papers 11
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 10
Stephen Greco
Johns Hopkins University School of Medicine
Co-authored papers 10
Luigi Marchionni
Weill-Cornell School of Medicine
Co-authored papers 10
Release 1.2